[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Janux Therapeutics, Inc. Common Stock (JANX)

Raymond James initiates coverage of JANX with an Outperform rating and a $XX target. Despite positive analyst ratings and high social engagement, JANX is down XXXX% in the last XX hours.

About Janux Therapeutics, Inc. Common Stock

Janux Therapeutics, Inc. Common Stock (JANX) is a biopharmaceutical company.
Janux Therapeutics, Inc. Common Stock uses the ticker $JANX for trading. Listed in the Stocks and category within the Healthcare sectors.

Insights #

Janux Therapeutics, Inc. Common Stock (JANX) trading volume is up XX% from the previous week.
Janux Therapeutics, Inc. Common Stock (JANX) galaxy score™ is up XXXXX% from the previous week.
Janux Therapeutics, Inc. Common Stock (JANX) sentiment is up XXXXX% from the previous week.

Price: $XXXXX #

Price 24-Hour Chart Data
Despite positive analyst ratings and high social engagement, JANX is down XXXX% in the last XX hours, likely due to broader negative market factors outweighing positive sentiment.

24-Hour	7-Day	30-Day
-XXXX%	XXXX%	XXXXX%

1-Year High: $XXXXX on 2024-12-04
1-Year Low: $XXXXX on 2025-05-14

AltRank: XXXXX #

AltRank Line Chart
AltRank 24-Hour Chart Data
Janux Therapeutics, Inc. Common Stock (JANX) is currently AltRank #2,053 based on combined combined social and market metrics Daily Average: XXX
1 Week: XXXXX +530
1 Month: XXXXX +245
6 Months: XXXXX +1,234
1 Year: XXXXX +1,431
1-Year High: XXXXX on 2025-06-27
1-Year Low: X on 2024-12-04

Galaxy Score: XXXXX #

Galaxy Score Line Chart
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +12
1 Month: XX -X
6 Months: XX +1
1 Year: XX -XX
1-Year High: XX on 2024-08-14
1-Year Low: XX on 2025-07-10

Engagements: XXX #

Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXX -XX%
6 Months: XXXXXXX -XX%
1 Year: XXXXXXXXX +66%
1-Year High: XXXXXXX on 2024-12-03
1-Year Low: XX on 2025-07-20

Social Network	X	Reddit
Engagements	XXX	X

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXX +444%
6 Months: XXXXX -XX%
1 Year: XXXXX +266%
1-Year High: XXX on 2024-12-05
1-Year Low: X on 2025-07-20

Social Network	X	Reddit
Mentions	XX	X

Creators: XX #

Creators Line Chart
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Janux Therapeutics, Inc. Common Stock (JANX) in the last XX hours which is up XXXX% from XX in the previous XX hours Daily Average: XX
1 Week: XX -XX%
1 Month: XXX +903%
6 Months: XXXXX +2.10%
1 Year: XXXXX +258%
1-Year High: XXX on 2024-12-04
1-Year Low: X on 2025-07-20

The most influential creators that mention Janux Therapeutics, Inc. Common Stock in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@SeekingAlpha	X	XXXXXXX	X	XXX

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +33%
1 Month: XX% -XX%
6 Months: XX% +9%
1 Year: XX% +14%
1-Year High: XXX% on 2024-09-29
1-Year Low: XX% on 2024-07-31

Most Supportive Themes

Analyst Outperform Rating: (80%) Raymond James initiated coverage of JANX with an outperform rating and a $XX price target, indicating strong confidence in the stock.
Tumor-Conditional Masking Platform: (10%) Janux Therapeutics' tumor-conditional masking platform is attracting attention.
Acquisition Target: (5%) The company is considered an attractive acquisition target.

Most Critical Themes

Market Factors vs. Social Sentiment: (3%) Market factors are negatively impacting stock prices despite high social engagement.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	XXX	XX%	XXX	XX%	XX	X%
Reddit	X	X%	X	X%	X	X%

Total	XXX	XX%	XXX	XX%	XX	X%

Social Dominance: XXXXXXX% #

Social Dominance Line Chart
Social Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: XXXX%
1 Week: XXXXXXX% -XXXXXXX%
1 Month: XXXXX% +0.0047%
6 Months: XXXXX% -XXXXXX%
1 Year: XXXXX% +0.0043%
1-Year High: XXXXX% on 2024-12-05
1-Year Low: XXXXXX% on 2025-07-15

Market Dominance: XXXXXXX% #

Market Dominance Line Chart
Market Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2024-11-05
1-Year Low: XXXXXXX% on 2025-07-19

Market Cap: $XXXXXXXXXXXXX #

Market Cap Line Chart
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$5.10%
1 Month: $XXXXXXXXXXXXX +$16%
6 Months: $XXXXXXXXXXXXX -$34%
1 Year: $XXXXXXXXXXXXX -$32%
1-Year High: $XXXXXXXXXXXXX on 2024-12-04
1-Year Low: $XXXXXXXXXXXXX on 2025-05-14

Top assets mentioned In the posts about Janux Therapeutics, Inc. Common Stock in the last XX hours

Strategy (MSTR) Lumen Technologies Inc (LUMN) Johnson & Johnson (JNJ) Regeneron Pharmaceuticals Inc (REGN) Akropolis (AKRO) WalletConnect Token (WCT) Applovin Corporation (APP) Core Scientific, Inc. Common Stock (CORZ) Rocket Lab USA, Inc. Common Stock (RKLB)

Top topics mentioned In the posts about Janux Therapeutics, Inc. Common Stock in the last XX hours

investment, mstr, lev, asts, mars, bnt, itrm, nvda, vera, pinetwork, $mstr, nio, mei, $hcti, $lumn, $ctos, $lixt, donald trump, raymond james, $jnj, $regn, mos, sre, pen, njr, barbadian or bajan dollar, ast, $hsdt, $pbm, sonn, acquisition, tars, palantir, $iron, op, $tecx, $akro, welcome to, linkedin, $janxi, vir, sli, wct, mira, $cxai, $wct, $ysxt, $mtem, $svmh, $foxx, $prfx, ford, xyz, $ford, jnj, $hspou, $fbrx, $fgn, $pzza, virtual, $psnl, sln, $vrdn, $syre, $rckt, 25m, market cap, $25m, $cmrx, $kala, $nbtx, $gyre, $bdtx, vvv, luv, qqq, spx, $gcv, iag, indian rupee, $rell, $cenx, $hlvx, united states, lucid group, $app, cfg, metc, bmnr, $nen, $corz, $rklb, $bgt, $eicb, $sfst, $efxt, $bfst, dg, aap, gps